Indole derivative used as CRTH2 inhibitor

US10800765B2 · kind B2 · utility

Assignee

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

• Yuanshan Yao · Shanghai, CN
• Bin Chen · Shanghai, CN
• Yuan Chen · Shanghai, CN
• Ao Li · Nanjing, CN
• Ran Xu · Houston, US
• Zhensheng Huang · Shanghai, CN
• Dongdong Tian · Tangxia, CN
• Hongwei Li · Burnaby, CA
• Chengshuai Yang · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jul 21, 2017
• Grant date: Oct 13, 2020
• Expiry date: Jul 21, 2037

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D495/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.